11x Series A - 1.91x1
11x Secures $24 Million Series A Funding Led by Benchmark to Create the Future of Digital Work
September 16, 2024 12:00 ET | 11X AI INC.
11x secures $24 million Series A funding led by Benchmark to create the future of digital work.
 SOLASTA BIO COMPLETES $14M SERIES A TO ACCELERATE NATURE-INSPIRED CROP PROTECTION
SOLASTA Bio Completes $14m Series A to Accelerate Nature-Inspired Crop Protection
September 11, 2024 04:51 ET | SOLASTA Bio Ltd.
SOLASTA Bio, a leading agri-biotech company specialising in the next generation of green insecticides, has completed an oversubscribed $14 million Series A
Radiance BioPharma sponsoring Investor Cruise Event 2024
August 29, 2024 15:30 ET | Radiance BioPharma
BOSTON, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Radiance Biopharma Inc., a biopharmaceutical company developing next generation Antibody Drug Conjugates and Bispecific Antibody Drug Conjugates announced...
S64-logo-blue-1.png
S64 Announces Successful Close of Series A Funding Round with investments from HPS Investment Partners and Sumitomo Mitsui Trust Bank
July 29, 2024 03:55 ET | S64 Capital
LONDON, July 29, 2024 (GLOBE NEWSWIRE) -- S64, the global alternatives fintech and solutions partner to the wealth management industry, today announced the successful close of its Series A funding...
FUZE_Vector Logos-09.png
FUZE Technology Secures $11.5M in Series A Funding to Propel Global Expansion of IoT Hardware and Software
June 13, 2024 08:00 ET | FUZE Technology
FUZE Technology (“FUZE”) announces the close of the company's Series A funding round, securing $11.5 million. FUZE also announces adFUZE.
Amber Tx logo.png
Amber Therapeutics Closes $100 Million Series A Financing to Advance Breakthrough Amber-UI Neuromodulation Therapy for Mixed Urinary Incontinence towards US FDA Approval
June 10, 2024 03:00 ET | Amber Therapeutics
US approval would make Amber-UI the first fully implantable adaptive neuromodulation therapy for women with mixed urinary incontinence (MUI)By targeting the pudendal nerve, Amber-UI has the unique...
Therini Bio Logo.jpg
Therini Bio Announces Positive Preclinical Data Supporting the Development of THN391 in Neurodegenerative Ocular Diseases
May 08, 2024 09:00 ET | Therini Bio, Inc.
THN391, a mAb designed to block neuroinflammation triggered by fibrin, demonstrated effectiveness in protecting against vascular and neuronal degeneration
K4-MA-SE-TX-L1.jpg
Keiretsu Forum Sponsors Quix Labs at the Innovation Funders Showcase During Angel Capital Association's Annual Summit
April 24, 2024 07:08 ET | Keiretsu Forum Mid-Atlantic
Keiretsu Forum Mid-Atlantic, South-East, and Texas regions proudly announce their sponsorship of Quix Labs at the upcoming Innovation Funders Showcase.
Captura_Logo_DarkGreen_RGB.png
Carbon removal firm Captura expands Series A funding to US$45.3M
April 11, 2024 03:01 ET | Captura Corporation
Captura has announced it has further expanded its Series A funding round leading to a total of US$45.3M.
Onum logo-color.png
Onum raises $28M to help businesses extract more value from their data at lower costs
April 10, 2024 08:00 ET | Onum
Onum, which gives companies control over their data, cost, and performance, announced today that it has raised a $28 million Series A funding round.